Bio Essence Corporation
BIOE
$0.19
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 31.50% | -80.04% | 7,816.15% | -78.30% | 129.11% |
| Total Depreciation and Amortization | 103,500.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.00% | -32.39% | -24.47% | -18.97% | -15.94% |
| Change in Net Operating Assets | 49.15% | -403.81% | 24.50% | 70.82% | -41.95% |
| Cash from Operations | 114.49% | -133.20% | 563.69% | 11.44% | 742.91% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -200.00% | 241.29% | -42.10% | 170.02% | -76.76% |
| Total Debt Repaid | 199.48% | 69.84% | -271.84% | -51.27% | 22.78% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.30% | 135.29% | -702.65% | 5.72% | -779.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.07% | 226.13% | -200.00% | -- | 100.00% |